Kayentis is a global leader in electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial solutions.

Since 2005, Kayentis has supported pharma, biotechs and CROs in streamlining data collection and enhancing the quality of clinical trials. With expertise spanning all phases (I–IV) and more than 200 indications across over 20 therapeutic areas, Kayentis delivers a comprehensive suite of services designed for science-driven and patient-centric research.

Operating across the US, Europe and Asia, Kayentis is committed to innovation and excellence, continually adapting its solutions to meet the growing complexity of global clinical trials and to improve outcomes for sponsors, sites and patients.

Learn how RWS and Kayentis work together.